Fetal hippocampal CA3 cell grafts exhibit dramatically enhanced survival when transplanted at an early postlesion delay of 4 days into the lesioned CA3 region of adult hippocampus. However, survival of these homotopic grafts following placement at late postlesion time points when the host milieu is considerably less receptive to grafts is unknown. We hypothesize that an extended postlesion delay at the time of grafting will lead to significant diminution in cell survival of both homotopic and heterotopic fetal transplants grafted to lesioned adult CNS. We quantitatively investigated absolute cell survival of 5′-bromodeoxyuridine-labeled fetal hippocampal CA3 and CA1 cell grafts, following transplantation into the lesioned CA3 region of adult rat hippocampus, at a delay of 45 days after a unilateral intracerebroventricular administration of kainic acid (KA). Survival of these grafts was also analyzed in intact CA3 of the hippocampus contralateral to KA administration for comparison. In lesioned CA3 region, CA3 (homotopic) and CA1 (heterotopic) grafts exhibited comparable but only moderate survival, with a recovery of only 21-31% of injected cells. Cell survival in these grafts into lesioned hippocampus was similar to survival of grafts placed into the contralateral intact CA3 region. These results are in sharp contrast to increased graft survival measured following transplants performed at 4 days postlesion. In such grafts placed early, there was both a significantly higher cell survival than grafts placed into the intact CA3 region and also a characteristic differential survival based on graft cell specificity to the lesioned CA3 region (Zaman et al., Exp. Neurol., 161:535-561, 2000). Thus, the enhanced conduciveness of lesioned CA3 region for survival of homotopic CA3 cell grafts observed at 4 days postlesion wanes by 45 days postlesion to that of intact CA3 region, in spite of residual loss of CA3 neurons with the lesion. Strategies that considerably augment graft cell survival may therefore be critical for optimal integration of fetal grafts into the adult CNS at late postlesion time points.
INTRODUCTION
and head injury (15, 22, 25, 34, 37, 44, (49) (50) (51) (52) 54, 58, 62) . Fetal hippocampal cell grafting studies in our laboratory are focused on lesion recovery in CA3-lesioned adult Transplantation of specific fetal neural tissue has been found to be useful in treating Parkinson's and Hunhippocampus following a unilateral intracerebroventricular (ICV) administration of kainic acid (KA). Because tington's diseases, and also has potential to treat other neurodegenerative disorders such as cerebral ischemia, ICV KA selectively eliminates CA3 pyramidal cells and preserves both CA1 pyramidal and dentate granule cells, temporal lobe epilepsy (TLE), and spinal cord injury (26, 28, 43, 46, 50, 61) . Studies in many lesion models have it provides an ideal model for studying the efficacy of different fetal grafts in mediating appropriate lesion reshown that grafting of specific fetal cells during early postlesion delay leads to both appropriate and enhanced covery in adult hippocampus, particularly assessing the role of both host and graft factors (5,35,36,49-52). lesion recovery in adult CNS (6, 7, 13, 46, 50, 55, 61) . Studies on the efficacy of fetal hippocampal cell grafts in Transplants containing fetal CA3 cells exhibit enhanced survival and integration in lesioned CA3 region different hippocampal lesion models may be useful in developing a graft-mediated therapy for TLE, ischemia, of adult hippocampus when grafted at an early post-lesion delay of 4 days, likely due to both an increase in points. We hypothesize that an extended postlesion delay at the time of grafting will lead to significant dimithe level of neurotrophic factors and also the denervation present following synaptic loss (18,23,29,35,36,38, nution in cell survival of both homotopic (specific) and heterotopic (nonspecific) fetal transplants grafted to le-39,49-52,64). Comparative analyses between homotopic and heterotopic fetal grafts at early postlesion desioned adult CNS. Hence, in the CA3 lesion model used here, both CA3 and CA1 cell grafts exhibit dramatically lay have further revealed that enhanced survival and efferent projections of fetal cell grafts in lesioned CA3 diminished cell survival following transplantation at 45 days postlesion compared with survival of similar grafts region critically depend upon their degree of specificity to the lesioned CA3 area (54, 64) , suggesting that grafttransplanted at 4 days postlesion (64). We quantitatively investigated cell survival of embryonic day (E) 19 hiping of fetal cells that are specific to the lesioned area results in maximal graft integration into the lesioned pocampal CA3 and CA1 cell micrografts (15,000 live cells) following transplantation into the lesioned CA3 host CNS. Enhanced survival and integration of specific neural grafts in lesioned adult hippocampus, when transregion of the adult hippocampus at 45 days post-ICV KA administration. Donor cells were labeled with 5′-planted at early postlesion delay, is likely applicable clinically for certain disorders such as severe stroke, bebromodeoxyuridine (BrdU) prior to grafting. Absolute cell survival within these grafts was analyzed using cause the area of damage is clearly demarcated. However, in most instances of potential application of hippoBrdU immunostaining and serial section reconstruction at 30 days postgrafting (48) (49) (50) 64) . For comparison, cell campal cell grafting to human neurodegenerative disorders, particularly TLE, grafting needs to be persurvival of these grafts was also quantified following transplantation into the intact CA3 of contralateral hipformed at late postlesion time points (i.e., many years after the lesion), when the host hippocampus has compocampus. pleted reorganization of circuitry and seizures persist MATERIALS AND METHODS and are clinically refractory to treatment. The combinaKainic Acid Lesions tion of aberrant, postlesion reorganization and the stabilization associated with recovery likely makes the host Young adult male Fisher 344 rats (Harlan-Spraguehippocampus less receptive to fetal grafts and graft-inDawley, n = 36, 180-220 g, 3-4 months old) were anesduced recovery. Thus, survival and integration of even thetized with a mixture of ketamine (50 mg/ml), xylaspecific (or homotopic) fetal grafts may be poor when zine (6 mg/ml), and acepromazine (0.5 mg/ml) at a dose grafted to lesioned hippocampus at later time points of 1.25 ml/kg body weight and fixed into a stereotaxic after lesion. Decreased survival of grafts transplanted at apparatus. In each of these rats, 0.4 µg of KA in 1 µl of late postlesion times could also result from waning of physiological saline was injected into the right lateral neurotrophic factors and ongoing reinnervation (even ventricle over a period of 20 min using the following though often inappropriate) following the lesion (29,35, coordinates: antero-posterior, 3.7 mm caudal to bregma; 36, 38, 39, 50) . lateral, 4.1 mm right lateral to midline; and ventral, 4.5 Our earlier study on mixed hippocampal cell grafts mm ventral to the surface of the brain. The incisor bars has demonstrated a clear reduction in graft cell survival were set at 3.7 mm below the interaural line. when transplantation occurred at late postlesion time
Labeling of Donor Hippocampal CA3 and CA1 Cells point (49). However, survival of homotopic CA3 cell
In Vivo grafts following placement at late postlesion time points is unknown in this kainate model. Because homotopic To label donor E19 hippocampal CA3 and CA1 cells, BrdU was injected intraperitoneally into timed pregnant fetal grafts have significantly greater promise for restoration of damaged circuitry and functional recovery than rats, as described in our earlier reports (48, 49, 64) . Briefly, BrdU was injected daily between E15 and E19 heterotopic or nonspecific fetal grafts, detailed analysis of survival and integration of homotopic fetal grafts in (one injection per day at a dose of 50 mg/kg body weight) and the cells harvested on E19. The schedule of lesioned adult hippocampus following grafting at late postlesion time points is critical in developing neural BrdU administration was derived from dates of neurogenesis for hippocampal CA3 and CA1 subfields. Begrafting therapy for TLE. A correct assessment of the degree of homotopic graft cell survival at different late cause the vast majority of neurons in these fields are generated (or become postmitotic) between E15 and E19 postlesion time points would be useful in determining the minimum number of homotopic cells required to be (2), the incorporation of BrdU in these neurons during this period is retained permanently. We have recently grafted to achieve maximal restoration of damaged circuitry at a particular postlesion time point. It would also shown that this labeling protocol gives a reliable and consistent labeling of the vast majority of cells and neulikely lead to the development of strategies that augment homotopic graft cell survival at late postlesion time rons in both CA3 and CA1 subfields (>92%) (64).
Collection of CA3 and CA1 Tissues, and Preparation Tissue Processing, Immunohistochemistry, and Analysis of Single Cell Suspension of BrdU-Labeled Cells in Different Transplants
One hour after the last BrdU injection, embryos were At 30 days following grafting, transplanted rats were removed from anesthetized pregnant rats by cesarean anesthetized and perfused transcardially first with 100 section, collected in a petri plate containing Hank's balml of normal saline containing 0.1% heparin and then anced salt solution (HBSS, Sigma), and brains dissected with 450 ml of 4% paraformaldehyde in 0.1 M phosunder an operating microscope (48, 49, 64) . Each cerebral phate buffer (PB, pH 7.2) over a period of 30 min. hemisphere was separated from the brain stem, cut coroBrains were removed, postfixed in 4% paraformaldenally into four slices of equal size, and slices containing hyde at 4°C for 12-18 h, washed in PB, cryoprotected hippocampal tissue were identified. Subfields CA3 (latin sucrose, and sliced coronally (20-µm-thick sections) eral most part of the hippocampus with choroid plexus) through the hippocampus using a cryostat. Sections were and CA1 (medial part of the hippocampus adjoining sucollected serially in 24-well plates and stored at 4°C. biculum) were then separated by sharp cuts and colEvery 12th section through the hippocampus was stained lected separately in fresh HBSS. The CA1 tissue colwith cresyl violet to localize the area of transplants and lected this way also contained the small, primordial also to measure the antero-posterior extent of different dentate gyrus, as this area could not be excluded by the transplants. Then, every sixth section through each above procedure. Using a fire-polished Pasteur pipette, transplant was processed for BrdU immunostaining us-CA3 and CA1 tissue pieces were separately triturated ing the ABC method, as detailed in our previous reports (30 times in 2 ml of HBSS), cell suspensions were (49,64). Diaminobenzidine (Vector kit) was used as sieved through a steel mesh (pore size = 175 µm), centrichromogen and sections were mounted onto gelatinfuged at 800 rpm for 8 min, and the pellets were resuscoated glass slides, air dried, dehydrated, cleared, and pended in HBSS. Cells were washed twice by resuspencover slipped using Permount. sion in HBSS and centrifugation. The final pellets were A total of 20 transplants belonging to the following resuspended in 30 µl of HBSS and viability assessed four transplant groups were analyzed: i) CA3 transplants using trypan blue exclusion method. The desired density in lesioned CA3 region (ipsilateral to ICV KA adminisof cells per microliter of HBSS was then adjusted for tration, n = 5); ii) CA3 transplants in intact CA3 region transplantation experiments (0.3 × 10 5 viable cells/µl) (contralateral to ICV KA administration, n = 5); iii) CA1 and stored on ice.
transplants in lesioned CA3 region (n = 5); iv) CA1 transplants in intact CA3 lesion, n = 5). Analysis of Transplantation Procedure transplants involved serial section reconstruction using Neurolucida (Microbrightfield, Vermont), as detailed in At 45 days postlesion, KA-lesioned rats were anesour earlier reports (48, 49, 64) . Serial reconstruction of thetized and fixed into a stereotaxic apparatus. The plane transplants allowed determination of the number of of incisor bar was set at 3.3 ± 0.3 mm below the interBrdU-positive cells recovered in terms of the absolute aural line. The skull was exposed through a midline incinumber of cells initially injected (the survival index) and sion and four burr holes [two sites ipsilateral to KA adalso the volume for every transplant. The measurement ministration (right side) and two sites contralateral to of survival index included correction for the number of KA administration (left side)] were drilled using stancells labeled with BrdU at the time of grafting (93% for dard coordinates for hippocampal cell transplantation CA3 cells and 95% for CA1), the number of sections (64). The coordinates included: 1) anterior-posterior counted (every sixth section), and also for split cell (AP) = 2.6 mm posterior to bregma, lateral (L) = 1.6 mm counts according to Abercrombie's formula [t/(t + d), right lateral to midline, and ventral (V) = 3.5 mm from where t = section thickness and d = nuclear diameter] the surface of the brain; 2) AP = 4.0 mm, L = 3.0 mm
(1). The average nuclear diameter of cells in both CA3 right lateral, and V = 3.5 mm; 3) AP = 2.6 mm posterior and CA1 cell grafts is detailed in our earlier report (64). to bregma, L = 1.6 mm left lateral, and V = 3.5 mm; 4)
In brief, the average nuclear diameter of BrdU-positive AP = 4.0 mm, L = 3.0 mm left lateral, and V = 3.5 mm. cells in CA3 cell grafts was 14.4 ± 0.5 µm (n = 100), The cell suspension was drawn into a 10-µl Hamilton which is significantly greater than the average nuclear syringe and inserted through the burr hole to a depth of diameter of cells in CA1 cell grafts (12.7 ± 0.4 µm, n = 3.5 mm from the surface of the brain. The cell suspen-100; p < 0.01). Thus, specific BrdU labeling of donor sion (0.5 µl) containing 15,000 live cells was then incells provided an excellent quantitative measure of graft jected slowly over a period of 4 min and the needle was cell survival for both CA3 and CA1 grafts in different left in place for an additional 8 min before withdrawal.
host conditions (lesioned CA3 vs. intact CA3). The difSkin was stapled and animals were returned to their cages.
ferences in both absolute cell survival index and volume between the four transplant groups were compared using to the intact CA3 cell layer, with greater part of the transplant extending into either the CA1 subfield above one-way analysis of variance (ANOVA) with NewmanKeuls multiple comparisons test.
or the lateral ventricle below.
RESULTS

Antero-Posterior Extent and Cytoarchitecture of CA3 and CA1 Transplants Viability and BrdU Labeling of E19 Hippocampal CA3 and CA1 Cells
Both CA3 and CA1 cell transplants grafted to lesioned CA3 exhibited very similar dispersion of grafted Viability of E19 hippocampal CA3 and CA1 cells cells along the antero-posterior axis (CA3 transplants, after dissociation and cell suspension preparation ranged mean ± SEM = 1.1 ± 0.07 mm; CA1 transplants = 0.9 ± from 75% to 80%, which is consistent with our previous 0.05 mm). These values are also comparable to anterostudy on these cells (64). The BrdU labeling index of posterior extent of their counterparts placed in intact E19 CA3 and CA1 cells following the BrdU labeling CA3 (hippocampus contralateral to KA administration; protocol employed here has been reported in detail re-CA3 transplants = 1.1 ± 0.1 mm; CA1 transplants = 1.0 cently and was found to be highly consistent between ± 0.05 mm). Comparison between different transplant animals (64). Ninety-two percent of CA3 cells and 95% groups did not show any difference (p > 0.1, ANOVA of CA1 cells were positive for BrdU at the time of graftwith Newman-Keuls multiple comparisons test). Nissl ing. Detailed characterization using tissue culture also staining demonstrated neurons within all CA3 and CA1 revealed that over 92% of neurons from both CA3 and transplants (Figs. 1 and 2). Moreover, the overall density CA1 cell suspensions were permanently labeled with of neurons in CA3 and CA1 transplants appeared similar BrdU (64).
on both ipsilateral and contralateral sides of KA admin-
Degree of Hippocampal Lesion Induced by Unilateral istration (Figs. 1 and 2). Neurons within CA3 transplants ICV KA Administration, and Location of Transplants
were primarily larger pyramidal cells and were arranged in clusters (Fig. 1) . The majority of neurons within CA1 Nissl-stained serial sections from lesioned, grafted transplants were of a smaller pyramidal shape and were animals were used to assess the degree of the KA-inhighly dispersed (Fig. 2) . A quantitative analysis of size duced hippocampal lesion and the location of different of neurons and immunocytochemical characterization of grafts within the hippocampus in both ipsilateral and pyramidal neurons between CA3 and CA1 cell transcontralateral sides of KA administration. Unilateral ICV plants in our recent study has clearly showed that the KA administration resulted in degeneration of ipsilateral morphology of neurons within these transplants respec-CA3 pyramidal and dentate hilar neurons, which is contively resemble hippocampal CA3 and CA1 neurons desistent with previous reports (35, 36, (49) (50) (51) (52) (53) (54) 64 ). Cells in veloped in situ (64). both CA1 and the dentate granule cell layers were spared on the side of lesion, except for a moderate loss Distribution of BrdU-Labeled Grafted Cells Within the of CA1 cells in only a few animals. In the hippocampus Host contralateral to ICV KA administration, CA3, CA1, and BrdU immunostaining of serial sections passing granule cell layers were intact. Distinct transplants were through transplants demonstrated distribution of grafted noted in all the grafted animals examined after sectioncells within the hippocampus. The distribution of BrdUing. However, for quantitative analysis of transplants uslabeled cells was comparable to the distribution of neuing BrdU immunostaining of serial sections, transplants rons within transplants in Nissl-stained neighboring secwere selected from only those animals that exhibited the tions. BrdU-positive grafted cells were conspicuous in following criteria: 1) a complete pyramidal cell loss in all CA3 and CA1 transplants grafted to both ipsilateral CA3b and CA3c and a partial cell loss in CA3a of the and contralateral sides of ICV KA administration (Figs. hippocampus ipsilateral to KA administration; 2) no ap-1 and 2). The distribution of BrdU-labeled cells apparent cell loss in CA1 and dentate granule cell layers peared very similar in all grafts, as they were mostly of the hippocampus ipsilateral to KA administration; 3)
found clustered around the injected site. Dispersion of intact CA3, CA1, and dentate granule cell layers in the cells away from the main mass of graft was rare. hippocampus contralateral to KA administration; and 4) transplants were located predominantly within the CA3
Absolute Survival Index and Graft Volume in Different region of the hippocampus. Transplants placed in the Grafts hippocampus ipsilateral to ICV KA administration always had a predominant fraction located along the deReconstruction of grafts from BrdU-immunostained serial sections facilitated quantitative measurement of generated CA3 cell layer, whereas transplants placed into the hippocampus contralateral to ICV KA adminisboth absolute graft cell survival and graft volume for different transplant groups. Absolute cell survival index tration demonstrated only a small fraction located close for CA3 and CA1 cell grafts in both ipsilateral and contralateral sides of KA administration is shown in Figure  3A . In lesioned CA3 region (hippocampus ipsilateral to ICV KA administration), CA3 cell grafts showed 31% cell survival whereas CA1 cell grafts showed 21% cell survival (Fig. 3A) . Interestingly, this degree of survival is highly comparable with survival of their counterparts in intact CA3 (hippocampus contralateral to ICV KA administration). In intact CA3, CA3 cell transplants exhibited 30% cell survival and CA1 cell transplants exhibited 23% cell survival (Fig. 3A) . Statistical comparison of graft cell survival using ANOVA revealed no difference in graft cell survival between the four transplant groups (p > 0.1). These results are in sharp contrast to survival of these grafts when transplanted at an early postlesion delay of 4 days (64). The degree of cell survival observed in both CA3 and CA1 cell transplants grafted to lesioned CA3 at 45 days postlesion is dramatically less than similar grafts transplanted at early postlesion delay. When grafted at an early postlesion delay of 4 days, CA3 cell grafts exhibited 69% cell survival and CA1 cell grafts demonstrated 42% cell survival. Moreover, grafts transplanted at early postlesion clearly exhibited differential survival based on their specificity to the lesioned CA3; grafts of fetal CA3 cells (specific homotopic grafts) showed significantly greater cell survival than grafts of fetal CA1 cells grafts (nonspecific heterotopic grafts). However, the degree of cell survival seen in CA3 and CA1 cell transplants grafted to contralateral intact CA3 at 45 days postlesion is comparable to similar grafts transplanted to contralateral intact CA3 at 4 days postlesion.
The volume of graft representing the total area of host tissue occupied by grafted cells was also measured and compared between different transplant groups (Fig.  3B) . The mean volume of CA3 cell transplants was 0.07 mm 3 in both lesioned and intact CA3 regions whereas the mean volume of CA1 transplants was 0.05 mm 3 for grafts transplanted to lesioned CA3 and 0.03 mm 3 for grafts transplanted to intact CA3 region. Comparison of graft volume using ANOVA showed no difference be- conduciveness of lesioned CA3 region for supporting graft cell survival was similar to that of intact CA3 reInterestingly, a recovery of 31% of injected cells observed here for fetal CA3 cell grafts transplanted at 45 gion, as fetal hippocampal cell grafts transplanted to both lesioned and intact CA3 regions showed comparadays postlesion is highly comparable to cell survival of grafts containing CA3 cells (mixed hippocampal grafts) ble graft cell survival. Further, in lesioned CA3, both homotopic (CA3) and heterotopic (CA1) cell grafts transplanted at 60 days postlesion (33% recovery) (49). This close similarity in the degree of cell survival bedemonstrated an equally reduced graft cell survival, revealing that grafting of even cells that are specific to the tween CA3 cell grafts transplanted at 45 days postlesion and mixed hippocampal cell grafts transplanted at 60 lesioned area does not result in enhanced graft cell survival after a postlesion delay of 45 days. These findings days postlesion suggests that the environment of lesioned CA3 region at late postlesion time points remains are in sharp contrast to the survival of fetal hippocampal cell grafts transplanted to similar regions at an early adequate for exerting survival of about a third of injected cells in grafts containing CA3 cells. This extent postlesion delay of 4 days (49,64). Thus, extensive postlesion delay at the time of grafting is not conducive for of graft cell survival, though significantly less compared with survival of similar grafts transplanted at 4 days good survival of even homotopic fetal grafts in lesioned adult hippocampus, in spite of the persistent and signifipostlesion, is significantly greater than survival of heterotopic dopaminergic grafts transplanted to the striatum cant lesion-induced cell loss in the CA3 region.
in Parkinson models (6, 13, 47) 45 Days Postlesion cells could be recovered at 1 month postgrafting. The extent of cell survival in these grafts also paralleled the Significantly decreased cell survival in hippocampal cell grafts transplanted to lesioned CA3 at 45 days postdegree of cell survival (23-30%) observed in similar grafts transplanted to intact CA3 region of the hippolesion, compared with similar grafts transplanted at 4 days postlesion, reflects substantial alterations in the campus contralateral to ICV KA administration. The overall pattern of cell survival observed for CA3 and host milieu with time after lesion, which becomes progressively less conducive for supporting immature CA1 cell grafts transplanted at 45 days postlesion is conspicuously distinct from that observed for CA3, CA1, grafted cells. At early time points following lesion, excellent survival of hippocampal cell grafts in lesioned and mixed hippocampal cell grafts transplanted at 4 days postlesion (49,64). Grafting at 4 days postlesion to le-CA3 is linked to the presence of multiple lesion-induced host factors (49,64). These factors are known to facilisioned CA3 resulted in enhanced graft cell survival (69-77% recovery of injected cells) for grafts containing tate survival of immature fetal cells, and include mainly the following: 1) presence of hypertrophied reactive CA3 cells compared with grafts containing only nonspecific CA1 cells (42% recovery of injected cells). Moreastrocytes and activated microglial cells; 2) elevated levels of many neurotrophic factors that support both surover, grafts containing CA3 cells showed significantly higher degree of graft cell survival in lesioned CA3 (69-vival and differentiation of fetal hippocampal neurons; and 3) availability of abundant vacant synaptic sites due 77%) compared with those placed in intact CA3 (26%) region (49,64). Thus, the pattern of cell survival in hipto the extensive denervation. Hypertrophied astrocytes and activated microglial pocampal cell grafts transplanted to lesioned CA3 at 45 days postlesion differs from similar grafts transplanted cells first appear at 3-4 days postlesion in lesioned CA3, show a dramatic increase in both number and size at 4 days postlesion by the following: 1) significantly decreased survival of grafted cells; 2) the loss of differbetween 11 and 26 days postlesion, and decline significantly thereafter (11, 32, 49) . The beneficial effect of hyential cell survival between specific (CA3) and nonspecific (CA1) grafts; and 3) comparable survival of CA3 pertrophied astrocytes and activated microglial cells for graft cell survival during this period is likely related to cell grafts as those grafted to intact CA3 region. These results underscore that the enhanced environment of the their release of cytokines and neurotrophic factors into the host environment (3, 8, 19, 20, 33, 40, 56, 59) . The cytolesioned adult CA3 region in terms of both survival and specificity observed at early postlesion delay is lost by kine interleukin-6 secreted by these cells stimulates the production of nerve growth factor (NGF), which is well 45 days postlesion. Thus, the persistent loss of CA3 neurons within the lesion is insufficient in itself to lead to known to rescue hippocampal neurons from undergoing excitotoxic cell death (16, 57, 63) . In addition, astrocytes enhanced survival of even homotopic fetal CA3 cell grafts.
are an excellent substrate for growing CNS neurons and microglial cells are known to condition cell surfaces for to enhance the survival of only those cell types that are appropriate to the region of grafting is no longer present enhanced neurite outgrowth (12, 14) . The elevated neurotrophic activity induced by CA3 lesion contains NGFat 45 days postlesion. Differential survival between CA3 and CA1 cell grafts transplanted at 4 days postlesion like activity [including NGF, brain derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3)] peaking belargely reflects differences in the degree of specific synaptic contacts these cells could make with the host neutween 4 and 30 days postlesion, ciliary neurotrophic factor (CNTF)-like activity peaking between 7 and 15 days, rons. Indeed, comparative studies on the integration of larger CA3 and CA1 cell grafts transplanted to lesioned and basic fibroblast growth factor (bFGF)-like activity peaking between 4 and 15 days (9,18,21,23,29,38,39,45 ).
CA3 at this postlesion time point clearly showed that only CA3 cell grafts integrated well with the host. Grafts Taken together, it is clear that increased levels of multiple neurotrophic factors that support survival of fetal containing CA3 cells, in contrast to grafts containing only CA1 cells, established robust projections to both hippocampal neurons and also protect them against hypoglycemic damage occur between 4 and 15 days postlocal and distant targets, received significant afferent host mossy fiber projections, and also significantly delesion, but are no longer present at 45 days postlesion (10, 60) . In addition, extensive denervation occurs in the creased aberrant sprouting of host mossy fibers into the dentate supragranular layer (51, 52, 54) . Thus, from the CA1 region following CA3 lesion (35, 36) during the initial postlesion period, due to loss of Schaffer collaterals.
pattern of survival of CA3 cell grafts transplanted at 4 days postlesion and those transplanted at 45 days postHowever, by 45 days postlesion, reinnervation by newly sprouted axons has occurred, and the synaptic density lesion, it appears that critical factors that promote survival, differentiation, and axon growth of CA3 neurons reaches the level of CA1 region in the intact hippocampus (35, 36) . Thus, events that are taking place in the during development reappear substantially in lesioned CA3 region at 4 days postlesion and undergo reduction CA3-lesioned hippocampus during the first 2 weeks after lesion are all highly favorable for enhanced suror completely disappear at 45 days postlesion. Factors that support survival of CA3 neurons in lesioned CA3 vival of hippocampal grafts transplanted at 4 days postlesion. The time course also suggests that the poor surat early postlesion likely include higher levels of neurotrophic factors NGF, BDNF, NT-3, and bFGF (9,18,21, vival of hippocampal grafts transplanted at 45 days postlesion, as observed in this study, is due to an altered 23, 29, 38, 39, 45) , expression of neural cell adhesion molecules (NCAMs) in denervated regions (31) that are spehost environment that is unfavorable for good survival of immature grafted cells. These include a significant cific for efferent connectivity of grafted CA3 neurons (31), and expression of embryonic markers (particularly decrease of hypertrophied astrocytes and activated microglial cells, a substantial decrease in the level of e-NCAM and other neural growth-promoting molecules) on the membrane of activated astrocytes and microglial various neurotrophic factors, and resolution of the denervation (though with potentially aberrant synapses).
cells. Indeed, reactive astrocytes appearing during early postlesion delay do express both nestin (a primitive neuBecause the latter environment is akin to that of intact hippocampus, the degree of graft cell survival in lerofilament protein expressed by all immature neural cells) and several neural growth-promoting molecules sioned CA3 at late times parallels that of the intact CA3 region. Clearly this result implies that grafted cells do particularly polysialated form or embryonic form of NCAM (e-NCAM), cell adhesion molecule L1, laminin, not detect the presence of cell loss alone, because CA3 cell loss persists at the 45-day postlesion time point, but fibronectin, and vascular endothelial growth factor (11, 14, 24, 27, 42) . In addition to these, possible reexpresrather the environment associated with the initial cell loss and its resolution back to a stable (but often inapsion of CA3 region-specific glycoproteins on reactive astrocytes could also be influencing enhanced survival propriate) recovery.
of 45 Days region-specific glycoproteins (4). Thus, both elevated Postlesion levels of neurotrophic factors and reexpression of many embryonic proteins in reactive astrocytes provide an In contrast to hippocampal grafts transplanted at 4 days postlesion, distinct hippocampal grafts transplanted ideal environment for survival and growth of homotopically grafted fetal CA3 neurons in lesioned CA3 region at 45 days postlesion did not exhibit differential cell survival based on their specificity to the lesioned CA3 reat early postlesion time points. And, a steady decline in both of these factors with increasing time after lesion gion. The lack of specificity when grafted at 45 days postlesion suggests that the intrinsic ability of the leresults in reduced survival of grafted CA3 neurons when transplanted at 45 days postlesion. Other factors leading sioned CA3 environment at early postlesion time points to specificity may include mossy fiber reinnervation they depend entirely on local host environment for survival (41) . Studies in other lesion models reporting sigonto early grafts, and with stabilization after the lesion there may be reduced mossy fiber in-growth onto transnificantly improved graft cell survival following pretreatment of grafted cells with both specific neurotrophic planted cells. If establishment of mossy fiber synapses onto immature CA3 cells, but not CA1 cells, is imporfactors and caspase inhibitors also support the strategy of pretreating grafted cells with specific factors tant for cell survival, this would also provide a basis for specific enhancement of homotopic graft cell survival at (30, 47, 65 This quantitative study demonstrates that extensive circuitry in the adult CNS (6, 7, 13, 46, 50, 61) . However, postlesion delay at the time of grafting significantly diin many instances of potential human application, fetal minishes cell survival within both homotopic and hetergrafts would need to be placed at later time points after otopic fetal grafts transplanted to lesioned adult CNS. the lesion, particularly neural grafting for chronic neuroTransplantation of fetal hippocampal grafts (including degenerative diseases such as epilepsy. This necessitates those containing only homotopic CA3 cells) to lesioned development of strategies that can enhance both survival CA3 region at a postlesion delay of 45 days led to sigand integration of neural grafts in lesioned adult CNS nificantly reduced graft cell survival in this study. Difollowing grafting at late postlesion time points. Potenminished cell survival within CA3 grafts clearly contial strategies to achieve this aim include grafting of a trasted with greatly enhanced cell survival observed in much larger number of cells, augmentation of the neurosimilar grafts transplanted at 4 days postlesion (64). trophic environment by adding exogenous factors toThus, the conduciveness of lesioned CA3 for enhanced gether with the graft, pretreatment of grafted cells with survival of specific fetal grafts at early postlesion is lost specific factors that decrease cell death related to graftby 45 days postlesion, likely due to a decrease in the ing trauma and hypoxia and that also can promote differlevel of neurotrophic factors, CA3 neuron-specific entiation of grafted neurons, and use of immature cells growth-promoting molecules, and vacant synaptic sites such as younger fetal hippocampal cells and hippocamin the lesioned hippocampus. Graft augmentation stratepal stem cells.
gies may be necessary for inducing optimal survival and Contiguous larger grafts likely enhance initial surintegration of fetal grafts transplanted at late postlesion vival by providing both trophic support and transient time points. synaptic sites, and the enhanced initial survival may subsequently lead to establishment of appropriate connec- and until the establishment of appropriate new synapses
